Showing 1 - 12 of 12 results
See how iFR Co-registration can change treatment decisions in comparison to angiographyThe use of iFR and now iFR Co-registration enables physicians to guide their decisions and interventions with clear physiologic data with regards to ischemia and flow limitations of specific lesions.
Patients with diffuse disease and renal dysfunction present challenging cases which require a variety of tools to successfully treatTreating patients with renal dysfunction requires unique techniques, technologies and workflow which can align well with the treatment of diffuse disease.
What are the best contrast reduction tools and techniques you use in your labs?AKI in today's lab is something that can be reduced when treating CKD patients by using the right tools and techniques to approach these fragile renal patients.
IVUS guided stent optimization case review with Dr. Jimmy KerriganWorkflow for a bifurcation PCI using Philips IVUS and SyncVision Co-registration to guide stent treatment
Functional guidance for PCI - imaging, physiology and co-registration practice integrationIn this virtual program, listen to Dr. Habib Samady and Dr. Catalin Toma review the most recent data highlighting the utilization of imaging, physiology and Co-registration to gain an understanding of ischemic pressure changes and key anatomic details which support precise PCI planning and optimization.
DEFINE PCI: A discussion of the 1-year results1 year results from the DEFINE PCI study: Residual ischemia and the value of physiologic guidance for PCI
PCI guidance with physiology and Co-registrationIn this program, Dr. Jeremias reviews and discusses key elements of iFR, its value in many lesion sets to understand the ischemic profile of lesions along the coronary vasculature as well as iFR’s role in facilitating PCI planning strategies, particularly for serial, diffuse and long lesions.
See clearly, treat optimally: using physiology and imaging to guide PCIUsing imaging and physiology to guide PCI. A live workshop case presentation from Baylor Scott& White Heart and Vascular Hospital- Plano, TX
See clearly and treat optimally with SyncVision’s iFR Co-registrationWith iFR Co-registration there is no need for hyperemic drugs, no need for time consuming pullback devices and no need for guesswork
Why should you use iFR Co-registration?iFR Co-registration graphically displays the iFR drop along the angiogram, highlighting which portion of the vessel is ischemic.
Advanced Physiologic GuidancePhysiologic lesion assessment not only identifies ischemia but can help to define and confirm optimal results post PCI. Click here to Learn More and hear from Experts
DEFINE PCI Unseen focal lesions cause residual ischemia1 in 4 patients with angiographically successful PCI left the cath lab with residual ischemia.Of the patients with residual ischemia, 81.6% were caused by an untreated angiographically inapparent physiologically focal stenosis (? 15 mm).